Gene therapy has transformed treatment for diseases like sickle cell and leukemia, but the methods used to deliver it can still carry risks. Researchers from U-M Engineering and Michigan Medicine are developing a new, non-viral approach to safely deliver genetic material into human cells, with early tests showing promise across multiple cell types.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.